Guardant Health Inc (GH)
22.88
+0.15
(+0.66%)
USD |
NASDAQ |
Sep 27, 16:00
22.91
+0.03
(+0.13%)
Pre-Market: 20:00
Guardant Health SG&A Expense (TTM): 463.31M for June 30, 2024
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
Date | Value |
---|---|
June 30, 2024 | 463.31M |
March 31, 2024 | 453.54M |
December 31, 2023 | 451.03M |
September 30, 2023 | 453.55M |
June 30, 2023 | 469.93M |
March 31, 2023 | 474.65M |
December 31, 2022 | 463.78M |
September 30, 2022 | 444.35M |
June 30, 2022 | 423.14M |
March 31, 2022 | 401.95M |
December 31, 2021 | 398.52M |
September 30, 2021 | 399.44M |
June 30, 2021 | 390.55M |
Date | Value |
---|---|
March 31, 2021 | 356.66M |
December 31, 2020 | 299.28M |
September 30, 2020 | 239.64M |
June 30, 2020 | 183.49M |
March 31, 2020 | 154.17M |
December 31, 2019 | 139.73M |
September 30, 2019 | 128.25M |
June 30, 2019 | 114.60M |
March 31, 2019 | 102.29M |
December 31, 2018 | 89.66M |
September 30, 2018 | 78.35M |
June 30, 2018 | 80.66M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (TTM) Range, Past 5 Years
128.25M
Minimum
Sep 2019
474.65M
Maximum
Mar 2023
359.45M
Average
400.69M
Median
SG&A Expense (TTM) Benchmarks
Exact Sciences Corp | 1.624B |
Illumina Inc | 1.374B |
Delcath Systems Inc | 28.74M |
CytoSorbents Corp | 37.41M |
Progyny Inc | 179.01M |